EB103

· Estrella Biopharma, Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for EB103, covering 2025-08-07 to 2025-08-07. Get the full timeline:

Most recent: Clinical Trial Update: T-Cell Therapy (EB103) in Adults With Relapsed/Refractory B-Cell Non-Hodgkin's Lymphoma (NHL) [Phase 1, Phase 2]